B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CA6

MOLECULAR TARGET

carbonic anhydrase 6

UniProt: P23280NCBI Gene: 76531 compounds

CA6 (carbonic anhydrase 6) is targeted by 31 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CA6

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Zonisamide2.4811
2Sulfanilamide2.208
3Indapamide2.087
4benzolamide1.956
5Mafenide1.795
6Celecoxib1.614
7Chlorthalidone1.614
8Sulpiride1.614
9Furosemide1.393
10Histamine1.393
11Tyrosine1.102
12Tyrosine1.102
13Bumetanide1.102
14Metolazone1.102
154-Hydroxybenzoate-3-Monooxygenase1.102
16stx641.102
17caffeic acid0.691
18Catechin0.691
19Histidine0.691
20Quercetin0.691
21Resveratrol0.691
22Spermidine0.691
23Bortezomib0.691
24Catechin0.691
25Famotidine0.691
26Vanillic Acid0.691
27Secologanin Tryptamine Alkaloids Compounds formed by condensation of secologanin with tryptamine resulting in0.691
28Lacosamide0.691
29Sildenafil Citrate0.691
30Spermine0.691
31thiamine0.691

About CA6 as a Drug Target

CA6 (carbonic anhydrase 6) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 31 compounds with documented CA6 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CA6 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.